Head of Cumberland Distribution gets 15-year sentence for drug diversion scam

gavel and money
The president of the former Cumberland Distribution has been sentenced to federal prison for running a $50 million drug diversion scheme. (AVNphotolab/Getty Images )

A Texas man who turned a drug diversion scheme into a $50 million business has bought himself a 15-year jail sentence.

Jerrod Nichols Smith, 48, of Houston, Texas, has been sentenced to 15 years in federal prison and ordered to forfeit $1.4 million.

Smith, the president of the now defunct Cumberland Distribution, was indicted in 2013 along with Charles Jeffrey Edwards, 56, and Brenda Edwards, 47, also of Houston, for operating the drug diversion scheme for nearly three years. The case was investigated by federal authorities including the FDA. 

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

RELATED: FDA alleges 3 made millions off scam wholesaler

They were accused of buying millions of dollars of prescription drugs from unlicensed suppliers who, in turn, bought the drugs from patients in and around New York and Miami. In most instances, Smith had these drugs shipped to Cumberland’s Nashville, Tennessee, warehouse where they were cleaned, sorted, re-packaged and shipped to independent pharmacies around the country. They created fake documents that indicated they had bought them from legal suppliers. 

The drugs included HIV/AIDS medications, antipsychotic medications, antidepressants, blood pressure medications and diabetes medications. But pharmacies reported problems with drugs, including prescription drug bottles containing the wrong medicine, the wrong dosage information and foreign objects. In one case, a bottle was filled with breath fresheners.    

Charles and Brenda Edwards previously pleaded guilty to related charges. Charles Edwards was sentenced to six years in prison and ordered to forfeit $1.4 million. Brenda Edwards will be sentenced later this year.

Read more on

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.